• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Researchers discover key to making new muscles

muscle regeneration atrophy

  • Please log in to reply
5 replies to this topic

#1 Antonio2014

  • Guest
  • 634 posts
  • 52
  • Location:Spain
  • NO

Posted 08 September 2014 - 11:43 AM


Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have developed a novel technique to promote tissue repair in damaged muscles. The technique also creates a sustainable pool of muscle stem cells needed to support multiple rounds of muscle repair. The study, published September 7 in Nature Medicine, provides promise for a new therapeutic approach to treating the millions of people suffering from muscle diseases, including those with muscular dystrophies and muscle wasting associated with cancer and aging.

 

There are two important processes that need to happen to maintain skeletal-muscle health. First, when muscle is damaged by injury or degenerative disease such as muscular dystrophy, muscle stem cells -- or satellite cells -- need to differentiate into mature muscle cells to repair injured muscles. Second, the pool of satellite cells needs to be replenished so there is a supply to repair muscle in case of future injuries. In the case of muscular dystrophy, the chronic cycles of muscle regeneration and degeneration that involve satellite-cell activation exhaust the muscle stem-cell pool to the point of no return.

 

"Our study found that by introducing an inhibitor of the STAT3 protein in repeated cycles, we could alternately replenish the pool of satellite cells and promote their differentiation into muscle fibers," said Alessandra Sacco, Ph.D., assistant professor in the Development, Aging, and Regeneration Program at Sanford-Burnham. "Our results are important because the process works in mice and in human muscle cells."

 

"Our next step is to see how long we can extend the cycling pattern, and test some of the STAT3 inhibitors currently in clinical trials for other indications such as cancer, as this could accelerate testing in humans," added Sacco.

 

Read the full article at ScienceDaily.



#2 PWAIN

  • Guest
  • 1,288 posts
  • 241
  • Location:Melbourne

Posted 08 September 2014 - 12:24 PM

So what are some STAT3 inhibitors?

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#3 Antonio2014

  • Topic Starter
  • Guest
  • 634 posts
  • 52
  • Location:Spain
  • NO

Posted 08 September 2014 - 01:07 PM

I don't know which inhibitors they used. I can't access their paper, only the abstract: http://www.nature.co...ll/nm.3656.html



#4 niner

  • Guest
  • 16,276 posts
  • 2,000
  • Location:Philadelphia

Posted 08 September 2014 - 02:22 PM

So what are some STAT3 inhibitors?

 

There are synthetic compounds, for example this, among others.  I just did a quick search for stat3 inhibitor.  I don't know if there's anything that's easy to get hold of.



#5 Logic

  • Guest
  • 2,659 posts
  • 587
  • Location:Kimberley, South Africa
  • NO

Posted 08 September 2014 - 04:50 PM

So what are some STAT3 inhibitors?


Some leads may be found on this site?:
http://www.google.co...=STAT3 protein

Zinc is mentioned here, but probably not very powerfull:
http://www.longecity...nhibition-help/

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#6 Avatar of Horus

  • Guest
  • 241 posts
  • 291
  • Location:Hungary

Posted 08 September 2014 - 06:18 PM

Instead of direct pharmacological inhibition of the given protein, another approach could be the identification the other proteins involved in its regulation, like in the connected signal transduction pathways, e.g. JAK/STAT, or functional modulation; that is to determine, in a broader sense, what can cause the dysregulation.

For example, in the case of STAT3, several such regulation proteins/mechanisms can be named: IL6, JAK, SOCS, PIAS proteins:
the infos are from the Medical Subject Headings - MeSH  http://www.nlm.nih.gov/mesh/

STAT3 Transcription Factor
A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-6 family members. STAT3 is constitutively activated in a variety of TUMORS and is a major downstream transducer for the CYTOKINE RECEPTOR GP130.

Janus Kinases
A family of intracellular tyrosine kinases that participate in the signaling cascade of cytokines by associating with specific CYTOKINE RECEPTORS. They act upon STAT TRANSCRIPTION FACTORS in signaling pathway referred to as the JAK/STAT pathway. The name Janus kinase refers to the fact the proteins have two phosphate-transferring domains.

Suppressor of Cytokine Signaling Proteins
A family of structurally related proteins that are induced by CYTOKINES and negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. SOCS proteins contain a central SH2 DOMAIN and a C-terminal region of homology known as the SOCS box.

Protein Inhibitors of Activated STAT
A family of structurally related proteins that are constitutively expressed and that negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. PIAS proteins inhibit the activity of signal transducers and activators of transcription.



Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).




Also tagged with one or more of these keywords: muscle, regeneration, atrophy

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users